healthcare

The following is a summary of the paper: “Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma: Is it time to challenge the standard-of-care?” by Gross, N. D., & Seiwert, T. Y. (2024), published in Cancer, explores the safety and potential benefits of using neoadjuvant immunotherapy in patients with resectable head…